Purchase 3-MeO-PCP
Discount program, second-order - 5%OFF, third-order - 7% OFF
With us securely! - re-shipment guarantees.
We always offer new legal products of impeccable quality.
Please make sure that the product is legal in your country and not under control before ordering.
We do not sell pharmaceutical products or controlled products.
Where to buy 3-MeO-PCP for sale
3-Methoxyphencyclidine (3-MeO-PCP) is a potent dissociative hallucinogen that has circulated on the market for designer drugs for several years. This chemical is linked to the well-known medication phencyclidine and belongs to the arylcyclohexylamine family (PCP). Although it has been offered as a designer medication, research on its effects and hazards is still being determined. This page intends to offer a thorough overview of 3-MeO-PCP, including its effects, modes of action, and potential concerns.
What is 3-MeO-PCP?
3-MeO-PCP is predominantly an NMDA receptor antagonist and a dissociative hallucinogen. It also interacts with the sigma 1 receptor and serotonin transporter. Contrary to many other drugs in their family, 3-MeO-PCP lacks opioid action and does not block dopamine absorption.
Mechanisms of Action
3-MeO-PCP principally functions as an NMDA receptor antagonist, inhibiting NMDA receptor activity and producing dissociative effects. The NMDA receptor plays a crucial role in controlling glutamate neurotransmission, which is involved in various physiological processes, including memory formation, pain perception, and mood regulation. 3-MeO-PCP can elicit various effects, including hallucinations, delusions, and out-of-body experiences, by inhibiting the action of this receptor.
3-MeO-PCP also interacts with the sigma 1 receptor and the serotonin transporter. The sigma 1 receptor regulates the release of several neurotransmitters, including dopamine and serotonin, whereas the serotonin transporter controls the absorption of serotonin into the synaptic cleft. These interactions may contribute to the 3-MeO-effects. PCP's
Effects of 3-MeO-PCP
Depending on the amount ingested, the effects of 3-MeO-PCP might vary from moderate to severe. The substance may elicit minor dissociative effects, such as a sensation of separation from one's surroundings or body, at lower dosages. The effects can be far more potent at greater dosages, including vivid hallucinations, delusions, and out-of-body experiences.
According to users, 3-MeO-PCP can generate various emotional effects, such as pleasure, excitement, and anxiety. The medicine can also cause physical side effects such as numbness, tingling, and muscular rigidity. In certain instances, users may suffer altered perception, in which objects or persons look distorted or foreign.
Potential Risks
As with any drug, there are possible dangers associated with 3-MeO-PCP consumption. The lack of existing studies makes it difficult to comprehend the possible long-term consequences of this drug's usage.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics
100g $600
100g $390
out of stock
1kg $1590
500g $1700
500g $1300
200g $690
100g $600
1kg $1590
100g $510
1kg $1690